市場調查報告書

CPAP (持續性陽壓呼吸器) 設備市場:目前分析與預測 - 自動化,零組件,應用,終端用戶 (醫院&診所、居家醫療),對地區及國的關注

Continuous Positive Airway Pressure CPAP Devices Market: Current Analysis and Forecast : Emphasis on Automation ; Component ; Application ; End-User (Hospitals & Clinics, Home Care, Others ) and Region and Country

出版商 UnivDatos Market Insights Pvt Ltd 商品編碼 968522
出版日期 內容資訊 英文 166 Pages
商品交期: 最快1-2個工作天內
價格
CPAP (持續性陽壓呼吸器) 設備市場:目前分析與預測 - 自動化,零組件,應用,終端用戶 (醫院&診所、居家醫療),對地區及國的關注 Continuous Positive Airway Pressure CPAP Devices Market: Current Analysis and Forecast : Emphasis on Automation ; Component ; Application ; End-User (Hospitals & Clinics, Home Care, Others ) and Region and Country
出版日期: 2020年07月01日內容資訊: 英文 166 Pages
簡介

全球CPAP (持續性陽壓呼吸器) 設備的市場規模,2019年是24億7520萬美金。由於COVID-19發生,全球地對CPAP設備的需求也提高。2020年的CRAP設備的市場規模,預計達到41億5120萬美元。可是,2021年市場預計恢復正常,從2021年到2026年的期間中,預計為8.62%的年複合成長率。

本報告提供全球CPAP (持續性陽壓呼吸器) 設備市場相關調查分析,市場概要,市場成長的影響要素,供需分析,價值鏈,各市場區隔的市場分析,競爭情形,及主要企業等相關的系統性資訊。

目錄

第1章 市場簡介

  • 市場定義
  • 調查的目的
  • 限制事項
  • 相關利益者
  • 報告所使用的貨幣
  • 全球CPAP設備市場調查範圍

第2章 調查手法或前提條件

  • 全球CPAP設備市場調查的調查手法
    • 全球CPAP設備市場調查的主要目的

第3章 產業的效能

第4章 摘要整理

第5章 CPAP設備的法律規範

  • 美國
  • 加拿大

第6章 市場概要

  • 簡介
    • 市場趨勢和推動要素
    • 市場阻礙因素
    • 市場趨勢

第7章 COVID-19治療中CPAP的使用

  • COVID-19治療中CPAP的使用的認證
  • COVID-19中的需求的管理

第8章 供需分析

  • 需求端分析
  • 供應端分析
    • 主要產品的銷售
    • 主要夥伴關係
    • 主要的合併和收購
    • 主要商務的擴大,投資及出售

第9章 CPAP設備的市場價值鏈

  • 主要的價值鏈分析

第10章 市場考察:各自動化

  • 整體概述
    • 手動CPAP設備
    • 自動CPAP設備

第11章 市場考察:各零件

  • 整體概述
    • CPAP馬達
    • CPAP加濕器
    • CPAP面罩
    • CPAP其他的配件

第12章 市場考察:各應用領域

  • 整體概述
    • 睡眠呼吸中止症
    • COPD
    • 其他的疾病

第13章 市場考察:各終端用戶

  • 整體概述
    • 醫院&診所
    • 居家醫療
    • 其他(睡眠實驗室)

第14章 市場考察:各地區

  • 整體概述
    • 北美
    • 歐洲
    • 亞太地區
    • 其他

第15章 競爭模式

  • 競爭情形

第16章 主要企業簡介

  • 3B Medical, Inc.
    • 主要資料
    • 營業內容
    • 主要的產品/服務的提供
    • 成長策略
    • SWOT分析
    • 最近的開發
  • Philips Respironics
  • Nidek medical
  • ResMed
  • Fisher and Paykel Healthcare
  • Teijin Pharma Limited
  • Drive DeVilbiss Healthcare
  • Koike Medical
  • BMC Medical Co., Ltd.
  • Fosun Pharma
目錄
Product Code: UMHE20185

Title:
Continuous Positive Airway Pressure CPAP Devices Market: Current Analysis and Forecast (2020-2026): Emphasis on Automation (Manual CPAP Devices, Automatic CPAP Devices); Component (CPAP Motors, CPAP Humidifier, CPAP Masks, CPAP Other Accessories); Application (Sleep Apnea, COPD, Others Diseases); End-User (Hospitals & Clinics, Home Care, Others (Sleep laboratories)) and Region and Country.

CPAP devices are majorly prescribed to the patients suffering from Obstructive Sleep Apnea (OSA). It is used to relieve the symptoms such as snoring by providing continuous air supply to the lungs. Among numerous advantages in sleep apnea patients, improved sleep quality and elimination of daytime sleepiness are also included. As the obesity rates are increasing the prevalence of sleep apnea will also be increased due to the direct relation of sleep apnea and BMI. More than half of people with OSA are either overweight or obese. Several types of CPAP devices are available in the market. These products can be automated or manual. Automated CPAP (also known as APAP) devices are designed to adjust the amount of pressure delivered on the breath by breath basis automatically. With the rising demand for a connected device, the demand of APAP will also increase. As CPAP data software enables patients and clinicians to analyze the sleep data by recording it. Motors, humidifiers, masks and accessories such as filters and hoses are the major components of CPAP devices. Earlier masks used to cover the entire face thus making it difficult for the patients. Currently, masks made are more comfortable and covers less area.

Based on the application, the market is segmented into sleep apnea, COPD and other diseases. Traditionally, sleep apnea is a disease that is majorly treated by CPAP devices. In 2019, Sleep apnea dominated the global CPAP device market, generating revenue of US$ 1,329.9 million in 2019. However, it is also used in patients suffering from bronchitis and neonates that have not developed their lungs properly. COPD is another disease that is treated by the equipment as it causes breathlessness (initially with exertion) and predisposes to exacerbations and serious illness. As the home care culture is on the rise the CPAP can be easily used by the patients in the home setting. Elder population suffers greatly from this disease. A trend has been observed showing that the elderly prefer to be treated in-home care settings as compared to the hospitals. Sleep laboratories also deploy the CPAP along with hospitals and clinics. Neonatal Intensive Care Unit (NICU) uses CPAP for providing air through the nose. In premature babies, CPAP is delivered through a set of nasal prongs or through a small mask that fits snugly over a baby's nose.

For a deep-dive analysis of the CPAP device, detailed regional-level analysis of North America (the U.S and Canada), Europe (Germany, France, Spain, Italy, and United Kingdom), Asia-Pacific (China, Japan, India, and Australia) and rest of the world has been conducted. North America generated revenue of US$ 909.5 million in 2019. However, Asia-Pacific is expected to witness the highest CAGR growth of 9.9% during the forecast period 2020-2026. 3B Medical, Inc., Philips Respironics, Nidek Medical, ResMed, Fisher and Paykel Healthcare, Teijin Pharma Limited, Drive Medical, Fosun Pharma, Koike Medical and BMC Medical. Several M&A's along with partnerships have been undertaken by these players to facilitate costumers with more efficient and innovative products.

Global Continuous Positive Airway Pressure (CPAP) device market stood at US$ 2,475.2 million in 2019. Owing to the COVID-19 outbreak demand for CPAP devices globally has increased. In 2020, the global market for Continuous Positive Airway Pressure (CPAP) device is expected to reach US$ 4,151.2 million. The market, however, in 2021 is expected to return to normal and would witness a CAGR growth of 8.62% during the 2021-2026 period.

TABLE OF CONTENTS

1. MARKET INTRODUCTION 15

  • 1.1 Market Definition 15
  • 1.2 Objective of the Study 15
  • 1.3 Limitation 15
  • 1.4 Stakeholders 16
  • 1.5 Currency used in the Report 16
  • 1.6 Scope of the Global CPAP Device Market Study 16

2. RESEARCH METHODOLOGY OR ASSUMPTION 17

  • 2.1 Research Methodology for the Global CPAP device Market Study 17
    • 2.1.1 Main objective of the Global CPAP device Market Study 18

3. INDUSTRY PERFORMANCE 19

4. EXECUTIVE SUMMARY 21

5. REGULATORY FRAMEWORK OF CPAP DEVICES 23

  • 5.1 United States 23
  • 5.2 Canada 24

6. MARKET OVERVIEW 26

  • 6.1 Introduction 26
    • 6.1.1 Market Trend & Drivers 26
      • 6.1.1.1 Rising Prevalence of Sleeping Disorders 26
      • 6.1.1.2 Greater Incidence of Sleep Apnea in Elderly Population 26
      • 6.1.1.3 Increasing Demand for CPAP-therapy 27
      • 6.1.1.4 Increasing Sales through E-Commerce 28
    • 6.1.2 Market Restraints 29
      • 6.1.2.1 High Cost of Device and Maintenance 29
      • 6.1.2.2 Poor Adherence to CPAP 29
    • 6.1.3 Market Trend 29
      • 6.1.3.1 Rising Demand for Home Care 29
      • 6.1.3.2 Infrastructural Advancements in the Medical and Healthcare Industry 30

7. CPAP USAGE IN THE COVID-19 TREATMENT 32

  • 7.1 Approval of Usage of CPAP as COVID-19 Treatment 32
  • 7.2 Managing the Demand during COVID-19 32

8. DEMAND AND SUPPLY SIDE ANALYSIS 34

  • 8.1 Demand Side Analysis 34
  • 8.2 Supply Side Analysis 35
    • 8.2.1 Top Product Launches 35
    • 8.2.2 Top Partnerships 37
    • 8.2.3 Top Mergers & Acquisitions 38
    • 8.2.4 Top Business Expansions, Investment and Divestitures 39

9. CPAP DEVICE MARKET VALUE CHAIN 40

  • 9.1 Key-Value Chain Analysis 40

10. MARKET INSIGHTS BY AUTOMATION 41

  • 10.1 General Overview 41
    • 10.1.1 Manual CPAP Devices 42
    • 10.1.2 Automatic CPAP Devices 43

11. MARKET INSIGHTS BY COMPONENT 44

  • 11.1 General Overview 44
    • 11.1.1 CPAP Motors 45
    • 11.1.2 CPAP Humidifier 46
    • 11.1.3 CPAP Masks 47
    • 11.1.4 CPAP Other Accessories 48

12. MARKET INSIGHTS BY APPLICATION 50

  • 12.1 General Overview 50
    • 12.1.1 Sleep Apnea 51
    • 12.1.2 COPD 52
    • 12.1.3 Others Diseases 53

13. MARKET INSIGHTS BY END-USER 55

  • 13.1 General Overview 55
    • 13.1.1 Hospitals & Clinics 56
    • 13.1.2 Home Care 56
    • 13.1.3 Others (Sleep laboratories) 58

14. MARKET INSIGHTS BY REGION 59

  • 14.1 General Overview 59
    • 14.1.1 North America CPAP Device Market 61
      • 14.1.1.1 United States CPAP Device Market 64
        • 14.1.1.1.1 Current US population is 331 million people 65
      • 14.1.1.2 Canada CPAP Device Market 67
      • 14.1.1.3 Rest of North America CPAP Device Market 71
    • 14.1.2 Europe CPAP Device Market 74
      • 14.1.2.1 Germany CPAP Device Market 78
      • 14.1.2.2 Russia CPAP Device Market 81
      • 14.1.2.3 Spain CPAP Device Market 83
      • 14.1.2.4 France CPAP Device Market 86
      • 14.1.2.5 United Kingdom CPAP Device Market 89
      • 14.1.2.6 Rest of Europe CPAP Device Market 92
    • 14.1.3 Asia-Pacific CPAP Device Market 94
      • 14.1.3.1 Japan CPAP Device Market 97
      • 14.1.3.2 China CPAP Device Market 100
      • 14.1.3.3 India CPAP Device Market 103
      • 14.1.3.4 Australia CPAP Device Market 106
      • 14.1.3.5 Rest of APAC CPAP Device Market 109
    • 14.1.4 Rest of World CPAP Device Market 112

15. COMPETITIVE SCENARIO 115

  • 15.1 Competitive Landscape 115
    • 15.1.1 Market Share of Key Players in CPAP Device Market, 2019 115

16. TOP COMPANY PROFILES 116

  • 16.1 3B Medical, Inc. 116
    • 16.1.1 Key Facts 116
    • 16.1.2 Business Description 116
    • 16.1.3 Key Product/Services Offerings 117
    • 16.1.4 Growth Strategy 117
    • 16.1.5 SWOT Analysis 118
    • 16.1.6 Recent Developments 118
      • 16.1.6.1 Product Launches 118
      • 16.1.6.2 Partnerships 119
      • 16.1.6.3 Business Expansions and Investment 119
      • 16.1.6.4 Mergers and Acquisitions 119
  • 16.2 Philips Respironics 120
    • 16.2.1 Key Facts 120
    • 16.2.2 Business Description 120
    • 16.2.3 Key Product/Services Offerings 120
    • 16.2.4 Growth Strategy 120
    • 16.2.5 SWOT Analysis 121
    • 16.2.6 Key Financials 122
      • 16.2.6.1 Revenue Split, by Region and Segment 123
    • 16.2.7 Recent Developments 124
      • 16.2.7.1 Product Launch 124
      • 16.2.7.2 Partnerships 124
  • 16.3 Nidek medical 125
    • 16.3.1 Key Facts 125
    • 16.3.2 Business Description 125
    • 16.3.3 Key Product/Services Offerings 125
    • 16.3.4 Growth Strategy 125
    • 16.3.5 SWOT Analysis 126
  • 16.4 ResMed 127
    • 16.4.1 Key Facts 127
    • 16.4.2 Business Description 127
    • 16.4.3 Key Product/Services Offerings 128
    • 16.4.4 Growth Strategy 128
    • 16.4.5 SWOT Analysis 129
    • 16.4.6 Key Financials 130
      • 16.4.6.1 Revenue Split, by Region and Segment 131
    • 16.4.7 Recent Developments 131
      • 16.4.7.1 Product Launches 131
      • 16.4.7.2 Partnerships 132
      • 16.4.7.3 Mergers and Acquisitions 132
  • 16.5 Fisher and Paykel Healthcare 133
    • 16.5.1 Key Facts 133
    • 16.5.2 Business Description 133
    • 16.5.3 Key Product/Services Offerings 134
    • 16.5.4 Growth Strategy 134
    • 16.5.5 SWOT Analysis 135
    • 16.5.6 Key Financials 136
      • 16.5.6.1 Revenue Split, by Region and Segment 137
    • 16.5.7 Recent Developments 137
      • 16.5.7.1 Product Launch 137
      • 16.5.7.2 Partnerships 138
  • 16.6 Teijin Pharma Limited 139
    • 16.6.1 Key Facts 139
    • 16.6.2 Business Description 139
    • 16.6.3 Key Product/Services Offerings 139
    • 16.6.4 Growth Strategy 139
    • 16.6.5 SWOT Analysis 140
    • 16.6.6 Key Financials 141
      • 16.6.6.1 Revenue Split, by Region and Segment 142
    • 16.6.7 Recent Developments 143
      • 16.6.7.1 Partnerships 143
      • 16.6.7.2 Mergers and Acquisitions 143
  • 16.7 Drive DeVilbiss Healthcare 144
    • 16.7.1 Key Facts 144
    • 16.7.2 Business Description 144
    • 16.7.3 Key Product/Services Offerings 144
    • 16.7.4 Growth Strategy 145
    • 16.7.5 SWOT Analysis 146
    • 16.7.6 Recent Developments 147
      • 16.7.6.1 Product Launch 147
      • 16.7.6.2 Partnerships 147
  • 16.8 Koike Medical 148
    • 16.8.1 Key Facts 148
    • 16.8.2 Business Description 148
    • 16.8.3 Key Product/Services Offerings 149
    • 16.8.4 Growth Strategy 150
    • 16.8.5 SWOT Analysis 151
  • 16.9 BMC Medical Co., Ltd. 152
    • 16.9.1 Key Facts 152
    • 16.9.2 Business Description 152
    • 16.9.3 Key Product/Services Offerings 152
    • 16.9.4 Growth Strategy 152
    • 16.9.5 SWOT Analysis 153
    • 16.9.6 Recent Developments 154
      • 16.9.6.1 Business Expansions and Investment 154
  • 16.10 Fosun Pharma 155
    • 16.10.1 Key Facts 155
    • 16.10.2 Business Description 156
    • 16.10.3 Key Product/Services Offerings 156
    • 16.10.4 Growth Strategy 157
    • 16.10.5 SWOT Analysis 158
    • 16.10.6 Key Financials 159
      • 16.10.6.1 Revenue Split, by Region and Segment 160
    • 16.10.7 Recent Developments 161
      • 16.10.7.1 Business Expansions and Investment 161
      • 16.10.7.2 Mergers and Acquisitions 161

List of Tables

  • TABLE 1 Price Comparison of CPAP Offered by Different Manufacturing Brands 29
  • TABLE 2 Comparison of CPAP and Weight Loss for the Treatment of OSA 35
  • TABLE 3 Top Product Launches 35
  • TABLE 4 Top Partnerships 37
  • TABLE 5 Top Mergers& Acquisitions 38
  • TABLE 6 Top Business Expansions, Investment and Divestitures 39
  • TABLE 7 Arterial oxygen saturation (Sa,O2) and time spent at a Sa,O2 of ?90% during treatment nights 43
  • TABLE 8 3B Medical, Inc. Company Key Facts 116
  • TABLE 9 Product segmentation of 3B Medical, Inc. 117
  • TABLE 10 3B Medical, Inc. Growth Strategy 117
  • TABLE 11 3B Medical, Inc. Product Launches 118
  • TABLE 12 3B Medical, Inc. Partnerships 119
  • TABLE 13 3B Medical, Inc. Business Expansions, Investment and Divestitures 119
  • TABLE 14 3B Medical, Inc. Mergers and Acquisitions 119
  • TABLE 15 Philips Respironics Key Facts 120
  • TABLE 16 Product segmentation of Philips Respironics 120
  • TABLE 17 Philips Respironics Growth Strategy 120
  • TABLE 18 Philips Respironics Product Launch 124
  • TABLE 19 Philips Respironics Partnerships 124
  • TABLE 20 Nidek medical Key Facts 125
  • TABLE 21 Product segmentation of Nidek medical 125
  • TABLE 22 Nidek medical Growth Strategy 125
  • TABLE 23 ResMed Key Facts 127
  • TABLE 24 ResMed Ownership Structure 127
  • TABLE 25 Product segmentation of ResMed 128
  • TABLE 26 ResMed Growth Strategy 128
  • TABLE 27 ResMed Product Launches 131
  • TABLE 28 ResMed Partnerships 132
  • TABLE 29 ResMed Mergers and Acquisitions 132
  • TABLE 30 Fisher and Paykel Healthcare Key Facts 133
  • TABLE 31 Fisher and Paykel Healthcare Ownership Structure 133
  • TABLE 32 Product segmentation of Fisher and Paykel Healthcare 134
  • TABLE 33 Fisher and Paykel Healthcare Growth Strategy 134
  • TABLE 34 Fisher and Paykel Healthcare Product Launch 137
  • TABLE 35 Fisher and Paykel Healthcare Partnerships 138
  • TABLE 36 Teijin Pharma Limited Key Facts 139
  • TABLE 37 The product segmentation of Teijin Pharma Limited 139
  • TABLE 38 Teijin Pharma Limited Growth Strategy 139
  • TABLE 39 Teijin Pharma Limited Partnerships 143
  • TABLE 40 Teijin Pharma Limited Mergers and Acquisitions 143
  • TABLE 41 Drive DeVilbiss Healthcare Key Facts 144
  • TABLE 42 Product segmentation of Drive DeVilbiss Healthcare 144
  • TABLE 43 Drive DeVilbiss Healthcare Growth Strategy 145
  • TABLE 44 Drive DeVilbiss Healthcare Product Launch 147
  • TABLE 45 Drive DeVilbiss Partnerships 147
  • TABLE 46 Koike Medical Key Facts 148
  • TABLE 47 Product segmentation of Koike Medical 149
  • TABLE 48 Koike Medical Growth Strategy 150
  • TABLE 49 BMC Medical Co., Ltd. Key Facts 152
  • TABLE 50 Product segmentation of BMC Medical Co., Ltd. 152
  • TABLE 51 BMC Medical Co., Ltd. Growth Strategy 152
  • TABLE 52 BMC Medical Co., Ltd. Business Expansions, Investment and Divestitures 154
  • TABLE 53 Fosun Pharma Key Facts 155
  • TABLE 54 Fosun Pharma Ownership Structure 155
  • TABLE 55 Product segmentation of Fosun Pharma 156
  • TABLE 56 Fosun Pharma Growth Strategy 157
  • TABLE 57 Fosun Pharma Business Expansions, Investment and Divestitures 161
  • TABLE 58 Fosun Pharma Mergers and Acquisitions 161

List of Figures

  • FIG. 1 Scope of the Global CPAP Device Market Study 16
  • FIG. 2 Research Methodology for the Global CPAP Device Market Study 17
  • FIG. 3 Global CPAP device Market by Value, 2019-2026 (US$ Million) 22
  • FIG. 4 Prevalence of Sleep Apnea by Age Group and Sex 26
  • FIG. 5 Prevalence of Sleep Apnea in Adult Males, by Age Group 27
  • FIG. 6 Improvement in quality of Life with CPAP Treatment 28
  • FIG. 7 Change in Ecommerce Sales of SleepEh 28
  • FIG. 8 CPAP Machines 30
  • FIG. 9 Sleep Disorder Statistics in the US 34
  • FIG. 10 Value Chain Analysis in CPAP Device Market 40
  • FIG. 11 Global CPAP Device Market Share by Automation, 2019 & 2026 (%) 41
  • FIG. 12 Global CPAP Device Market by Automation, 2019-2026 (US$ Million) 41
  • FIG. 13 Global Manual CPAP Device Market by Region, 2019-2026 (US$ Million) 42
  • FIG. 14 Global Automatic CPAP Device Market by Region, 2019-2026 (US$ Million) 43
  • FIG. 15 Block Diagram of the Experimental CPAP Setup 44
  • FIG. 16 Global CPAP Device Market Share by Component, 2019 & 2026 (%) 44
  • FIG. 17 Global CPAP Device Market by Component, 2019-2026 (US$ Million) 45
  • FIG. 18 Global CPAP Motors Market by Region, 2019-2026 (US$ Million) 46
  • FIG. 19 Global CPAP Humidifier Market by Region, 2019-2026 (US$ Million) 46
  • FIG. 20 CPAP Masks, by Type 47
  • FIG. 21 Global CPAP Masks Market by Region, 2019-2026 (US$ Million) 48
  • FIG. 22 Global CPAP Other Accessories Market by Region, 2019-2026 (US$ Million) 49
  • FIG. 23 Global CPAP Device Market Share by Application, 2019 & 2026 (%) 50
  • FIG. 24 Global CPAP Device Market Size by Application, 2019-2026 (US$ Million) 50
  • FIG. 25 Prevalence of OSA, by Country (in Million) 51
  • FIG. 26 Prevalence of Sleep Conditions in Australia (in Percentage) 51
  • FIG. 27 Global CPAP Sleep Apnea Application Market by Region, 2019-2026 (US$ Million) 52
  • FIG. 28 Prevalence of COPD among U.S. adults as of 2017, by smoking status and age 53
  • FIG. 29 Global CPAP COPD Application Market by Region, 2019-2026 (US$ Million) 53
  • FIG. 30 Global CPAP Other Diseases Application Market by Region, 2019-2026 (US$ Million) 54
  • FIG. 31 Global CPAP Device Market Share by End-User, 2019 & 2026 (%) 55
  • FIG. 32 Global CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 55
  • FIG. 33 Global CPAP Hospitals & Clinics End-User Market by Region, 2019-2026 (US$ Million) 56
  • FIG. 34 Health Care Job Growth by Setting, Dec 2007- Jan 2017 57
  • FIG. 35 Global CPAP Home Care End-User Market by Region, 2019-2026 (US$ Million) 57
  • FIG. 36 Global CPAP Others (Sleep laboratories) End-User Market by Region, 2019-2026 (US$ Million) 58
  • FIG. 37 Obesity Rates by Region (Continent Summary) (2020) 59
  • FIG. 38 Time in Bed, by Country 59
  • FIG. 39 Global CPAP Device Market Share by Region, 2019 & 2026 (%) 60
  • FIG. 40 Global CPAP Devices Market by Region, 2019-2026 (US$ Million) 60
  • FIG. 41 Obesity Rates By Country, North America (2020) 61
  • FIG. 42 North America CPAP Device Market by Automation, 2019-2026 (US$ Million) 62
  • FIG. 43 North America CPAP Device Market by Component, 2019-2026 (US$ Million) 62
  • FIG. 44 North America CPAP Device Market Size by Application, 2019-2026 (US$ Million) 63
  • FIG. 45 North America CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 63
  • FIG. 46 North America CPAP Device Market Size by Country, 2019-2026 (US$ Million) 64
  • FIG. 47 Percentage and Severity of Sleep Apnea in US Population 64
  • FIG. 48 Facts Regarding Sleep Apnea in the United States 65
  • FIG. 49 US CPAP Device Market by Automation, 2019-2026 (US$ Million) 65
  • FIG. 50 US CPAP Device Market by Component, 2019-2026 (US$ Million) 66
  • FIG. 51 US CPAP Device Market Size by Application, 2019-2026 (US$ Million) 66
  • FIG. 52 US CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 67
  • FIG. 53 Distribution Adults Aged 18-79 While Going to sleep among, by Sex (Canada 2016,2017) 67
  • FIG. 54 Prevalence of Sleep Apnea among Adults, Canada (by Age Group, Sex) 68
  • FIG. 55 Sleep Apnea Symptoms and Risk Factor among Adults in Canada Aged 18-79, by Sex (2016,2017) 68
  • FIG. 56 Canada CPAP Device Market by Automation, 2019-2026 (US$ Million) 69
  • FIG. 57 Canada CPAP Device Market by Component, 2019-2026 (US$ Million) 69
  • FIG. 58 Canada CPAP Device Market Size by Application, 2019-2026 (US$ Million) 70
  • FIG. 59 Canada CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 70
  • FIG. 60 Obesity Rates By Country, Rest of North America (2020) 71
  • FIG. 61 Rest of NA CPAP Device Market by Automation, 2019-2026 (US$ Million) 72
  • FIG. 62 Rest of NA CPAP Device Market by Component, 2019-2026 (US$ Million) 72
  • FIG. 63 Rest of NA CPAP Device Market Size by Application, 2019-2026 (US$ Million) 73
  • FIG. 64 Rest of NA CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 73
  • FIG. 65 European Countries with the Highest Prevalence of Sleep Apnea (in Million) 74
  • FIG. 66 Patients likely to Suffer from Sleep Apnea with Medical Conditions in Europe 74
  • FIG. 67 Obesity Rates By Country, Europe (2015 & 2020) 75
  • FIG. 68 Europe CPAP Device Market by Automation, 2019-2026 (US$ Million) 75
  • FIG. 69 Europe CPAP Device Market by Component, 2019-2026 (US$ Million) 76
  • FIG. 70 Europe CPAP Device Market Size by Application, 2019-2026 (US$ Million) 76
  • FIG. 71 Europe CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 77
  • FIG. 72 Europe CPAP Device Market Size by Country, 2019-2026 (US$ Million) 77
  • FIG. 73 Prevalence Estimates of OSA and OSA Syndrome in Germany, by Gender 78
  • FIG. 74 Prevalence Estimates of OSA and OSA Syndrome in Germany, by Age 78
  • FIG. 75 Germany CPAP Device Market by Automation, 2019-2026 (US$ Million) 79
  • FIG. 76 Germany CPAP Device Market by Component, 2019-2026 (US$ Million) 79
  • FIG. 77 Germany CPAP Device Market Size by Application, 2019-2026 (US$ Million) 80
  • FIG. 78 Germany CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 80
  • FIG. 79 Standardized Death Rates (SDR) of Respiratory Diseases per 100,000 population in Russian 81
  • FIG. 80 Russia CPAP Device Market by Automation, 2019-2026 (US$ Million) 81
  • FIG. 81 Russia CPAP Device Market by Component, 2019-2026 (US$ Million) 82
  • FIG. 82 Russia CPAP Device Market Size by Application, 2019-2026 (US$ Million) 82
  • FIG. 83 Russia CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 83
  • FIG. 84 Relative Size of Population in Spain, (1950-2050) 83
  • FIG. 85 Overweight Population in Spain, in Million (2010,2019& 2030) 84
  • FIG. 86 Spain CPAP Device Market by Automation, 2019-2026 (US$ Million) 84
  • FIG. 87 Spain CPAP Device Market by Component, 2019-2026 (US$ Million) 85
  • FIG. 88 Spain CPAP Device Market Size by Application, 2019-2026 (US$ Million) 85
  • FIG. 89 Spain CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 86
  • FIG. 90 Relative Size of Population in France, (1950-2050) 86
  • FIG. 91 France CPAP Device Market by Automation, 2019-2026 (US$ Million) 87
  • FIG. 92 France CPAP Device Market by Component, 2019-2026 (US$ Million) 87
  • FIG. 93 France CPAP Device Market Size by Application, 2019-2026 (US$ Million) 88
  • FIG. 94 France CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 88
  • FIG. 95 Prevalence of Sleep Apnea in the UK (by Sex) 89
  • FIG. 96 Finished Admission Episodes with a primary diagnosis of obesity in England, by gender 89
  • FIG. 97 UK CPAP Device Market by Automation, 2019-2026 (US$ Million) 90
  • FIG. 98 UK CPAP Device Market by Component, 2019-2026 (US$ Million) 90
  • FIG. 99 UK CPAP Device Market Size by Application, 2019-2026 (US$ Million) 91
  • FIG. 100 UK CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 91
  • FIG. 101 Obesity Rates By Country, Rest of Europe (2015 & 2020) 92
  • FIG. 102 Rest of EU CPAP Device Market by Automation, 2019-2026 (US$ Million) 92
  • FIG. 103 Rest of EU CPAP Device Market by Component, 2019-2026 (US$ Million) 93
  • FIG. 104 Rest of EU CPAP Device Market Size by Application, 2019-2026 (US$ Million) 93
  • FIG. 105 Rest of EU CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 94
  • FIG. 106 Obesity Rates By Country, APAC (2015 & 2020) 94
  • FIG. 107 Asia-Pacific CPAP Device Market by Automation, 2019-2026 (US$ Million) 95
  • FIG. 108 Asia-Pacific CPAP Device Market by Component, 2019-2026 (US$ Million) 95
  • FIG. 109 Asia-Pacific CPAP Device Market Size by Application, 2019-2026 (US$ Million) 96
  • FIG. 110 Asia-Pacific CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 96
  • FIG. 111 Asia-Pacific CPAP Device Market Size by Country, 2019-2026 (US$ Million) 97
  • FIG. 112 Sleep Condition and Related Disorders in Workers, Japan (2017) 97
  • FIG. 113 Japan CPAP Device Market by Automation, 2019-2026 (US$ Million) 98
  • FIG. 114 Japan CPAP Device Market by Component, 2019-2026 (US$ Million) 98
  • FIG. 115 Japan CPAP Device Market Size by Application, 2019-2026 (US$ Million) 99
  • FIG. 116 Japan CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 99
  • FIG. 117 OSA Patient Treatment Choice in China, (in percentage) 100
  • FIG. 118 China CPAP Device Market by Automation, 2019-2026 (US$ Million) 101
  • FIG. 119 China CPAP Device Market by Component, 2019-2026 (US$ Million) 101
  • FIG. 120 China CPAP Device Market Size by Application, 2019-2026 (US$ Million) 102
  • FIG. 121 China CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 102
  • FIG. 122 Prevalence of Sleep Apnea in the Different Age Group, India 103
  • FIG. 123 India CPAP Device Market by Automation, 2019-2026 (US$ Million) 104
  • FIG. 124 India CPAP Device Market by Component, 2019-2026 (US$ Million) 104
  • FIG. 125 India CPAP Device Market Size by Application, 2019-2026 (US$ Million) 105
  • FIG. 126 India CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 105
  • FIG. 127 Common Sleep Problems Across the Adult Population in Australia 106
  • FIG. 128 Australia CPAP Device Market by Automation, 2019-2026 (US$ Million) 107
  • FIG. 129 Australia CPAP Device Market by Component, 2019-2026 (US$ Million) 107
  • FIG. 130 Australia CPAP Device Market Size by Application, 2019-2026 (US$ Million) 108
  • FIG. 131 Australia CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 108
  • FIG. 132 Obesity Rates by Country in Oceania, 2020 109
  • FIG. 133 Rest of APAC CPAP Device Market by Automation, 2019-2026 (US$ Million) 110
  • FIG. 134 Rest of APAC CPAP Device Market by Component, 2019-2026 (US$ Million) 110
  • FIG. 135 Rest of APAC CPAP Device Market Size by Application, 2019-2026 (US$ Million) 111
  • FIG. 136 Rest of APAC CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 111
  • FIG. 137 Obesity Rates by Country, 2020 112
  • FIG. 138 Rest of World CPAP Device Market by Automation, 2019-2026 (US$ Million) 113
  • FIG. 139 Rest of World CPAP Device Market by Component, 2019-2026 (US$ Million) 113
  • FIG. 140 Rest of World CPAP Device Market Size by Application, 2019-2026 (US$ Million) 114
  • FIG. 141 Rest of World CPAP Device Market Size by End-User, 2019-2026 (US$ Million) 114
  • FIG. 142 Market Share of Key Players in CPAP Device Market, 2019 (%) 115
  • FIG. 143 3B Medical, Inc. 117
  • FIG. 144 3B Medical, Inc. SWOT Analysis 118
  • FIG. 145 Philips, Products for Sleep Apnea 121
  • FIG. 146 Philips Respironics SWOT Analysis 121
  • FIG. 147 Key Financials of Royal Philips NV 122
  • FIG. 148 Philips Revenue Split, 2019 123
  • FIG. 149 Nidek medical, Special Features of Products 126
  • FIG. 150 Nidek medical, SWOT Analysis 126
  • FIG. 151 ResMed Products 128
  • FIG. 152 ResMed, Achievements 129
  • FIG. 153 ResMed, SWOT Analysis 129
  • FIG. 154 Key Financials of ResMed 130
  • FIG. 155 ResMed, Revenue Split, 2019 131
  • FIG. 156 Fisher & Paykel Healthcare, Values 135
  • FIG. 157 Fisher and Paykel Healthcare SWOT Analysis 135
  • FIG. 158 Key Financials of Fisher and Paykel Healthcare 136
  • FIG. 159 Fisher and Paykel Healthcare Revenue Split, 2019 137
  • FIG. 160 Teijin Pharma Limited, Timeline 140
  • FIG. 161 Teijin Pharma Limited, SWOT Analysis 140
  • FIG. 162 Key Financials of Teijin Pharma Limited 141
  • FIG. 163 Teijin Pharma Limited, Revenue Split, 2019 142
  • FIG. 164 DeVilbiss Healthcare, Sleep Therapy Products 146
  • FIG. 165 Drive DeVilbiss Healthcare SWOT Analysis 146
  • FIG. 166 Koike Medical Timeline 148
  • FIG. 167 Koike Medical, Business 151
  • FIG. 168 Koike Medical SWOT Analysis 151
  • FIG. 169 BMC Medical Co., Ltd, Products 153
  • FIG. 170 BMC Medical Co., Ltd, SWOT Analysis 153
  • FIG. 171 Fosun Pharma, Timeline 156
  • FIG. 172 Fosun Pharma, 2019 Milestones 157
  • FIG. 173 Fosun Pharma, 4 IN Strategy 158
  • FIG. 174 Fosun Pharma, SWOT Analysis 158
  • FIG. 175 Key Financials of Fosun Pharma 159
  • FIG. 176 Fosun Pharma, Revenue Split, 2019 160